Patient on $50,000-a-Week Cancer Drug Fears Leaving Behind H

After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the

Related Keywords

Texas , United States , Columbus , Ohio , White House , District Of Columbia , Sebastien Desprez , Merith Basey , Lamy Leach , Stacie Dusetzina , Paul Davis , Arthurg James , Hagop Kantarjian , Elizabeth Moreno , Vanderbilt University Medical Center , Department Of Leukemia , Blanchard Valley Health System In Findlay , Md Anderson Cancer Center , Blanchard Valley Health System , Cancer Hospital , Blanchard Valley , Valley Health System , England Based Immunocore , Cancer Center , Affordable Drugs , Trade , Medicine , He Economy , Inance , Harmacology , Ncology , Advertising , Jaw , Accounting , Health Care ,